EUVIMEDEUVIMED entdecken
Crossref

Targeted HBx gene editing by CRISPR /Cas9 system effectively reduces epithelial to mesenchymal transition and HBV replication in hepatoma cells

Preety Rawal iD, Dinesh Mani Tripathi iD, Hamed Hemati, Jitendra Kumar, Purnima Tyagi, Shiv Kumar Sarin iD, Vikrant Nain, Savneet Kaur iD

Liver International · 2024

DOI: 10.1111/liv.15805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2024. Verfasst von Preety Rawal und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology, Gautam Buddha University, Greater Noida, India. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis B. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Hepatitis B virus X protein (HBx) play a key role in pathogenesis of HBV‐induced hepatocellular carcinoma (HCC) by promoting epithelial to mesenchymal transition (EMT). In this study, we hypothesized that inhibition of HBx is an effective strategy to combat HCC. Methodology and Results We designed and synthesized novel HBx gene specific single guide RNA (sgRNA) with CRISPR/Cas9 system and studied its in vitro effects on tumour properties of HepG2‐2.15. Full length HBx gene was excised using HBx‐CRISPR that resulted in significant knockdown of HBx expression in hepatoma cells. HBx‐CRISPR also decreased levels of HBsAg and HBV cccDNA expression. A decreased expression of mesenchymal markers, proliferation and tumorigenic properties was observed in HBx‐CRISPR treated cells as compared to controls in both two‐ and three‐ dimensional (2D and 3D) tumour models. Transcriptomics data showed that out of 1159 differentially expressed genes in HBx‐CRISPR transfected cells as compared to controls, 70 genes were upregulated while 1089 genes associated with cell proliferation and EMT pathways were downregulated. Conclusion Thus, targeting of HBx by CRISPR/Cas9 gene editing system reduces covalently closed circular DNA (cccDNA) levels, HBsAg production and mesenchymal characteristics of HBV‐HCC cells. We envision inhibition of HBx by CRISPR as a novel therapeutic approach for HBV‐induced HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHepatitis BHumansHepatitis B virusHepatitis B Surface AntigensGene EditingCRISPR-Cas SystemsEpithelial-Mesenchymal TransitionRNA, Guide, CRISPR-Cas SystemsDNA, CircularVirus ReplicationHep G2 Cells

Stichwörter der Autor:innen

CRISPORHBV covalently closed circular DNA (cccDNA)cancer stem cells (CSCs)clustered regularly interspaced short palindromic repeats (CRISPR)differentially expressed genes (DEGs)epithelial to mesenchymal transition (EMT)hepatitis B virus (HBV)hepatocellular carcinoma (HCC)small guide RNA (sgRNA)three-dimensional spheroids

Substanzen

Hepatitis B Surface AntigensRNA, Guide, CRISPR-Cas SystemsDNA, Circular

Autor:innen und Institutionen

  • School of Biotechnology, Gautam Buddha University, Greater Noida, India.
  • Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, Delhi, India.
  • Department of Hepatology, Institute of Liver and Biliary Sciences, Delhi, India.

ORCID-Profile: Preety Rawal, Dinesh Mani Tripathi, Shiv Kumar Sarin, Savneet Kaur

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Rawal, P., Tripathi, D. M., Hemati, H., Kumar, J., Tyagi, P., Sarin, S. K., Nain, V., & Kaur, S. (2024). Targeted HBx gene editing by CRISPR /Cas9 system effectively reduces epithelial to mesenchymal transition and HBV replication in hepatoma cells. Liver International. https://doi.org/10.1111/liv.15805

Vancouver

Rawal P, Tripathi DM, Hemati H, Kumar J, Tyagi P, Sarin SK, et al. Targeted HBx gene editing by CRISPR /Cas9 system effectively reduces epithelial to mesenchymal transition and HBV replication in hepatoma cells. Liver International. 2024. doi:10.1111/liv.15805

BibTeX
@article{Rawal2024,
  author = {Rawal, Preety and Tripathi, Dinesh Mani and Hemati, Hamed and Kumar, Jitendra and Tyagi, Purnima and Sarin, Shiv Kumar and Nain, Vikrant and Kaur, Savneet},
  title = {Targeted HBx gene editing by CRISPR /Cas9 system effectively reduces epithelial to mesenchymal transition and HBV replication in hepatoma cells},
  journal = {Liver International},
  year = {2024},
  doi = {10.1111/liv.15805}
}
Kostenlos starten →